- Investing Ideas
- Polish Pharmaceuticals & Biotech Top Stock Picks from Analysts
Polish Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
4
Companies which are more than 50% undervalued based on analyst price target.
4 companies
Selvita
Market Cap: zł543.3m
Provides drug discovery, drug development, and contract testing services in Poland.
SLV
zł29.60
7D
-2.0%
1Y
-6.9%
Ryvu Therapeutics
Market Cap: zł344.5m
A clinical-stage drug discovery and development company, engages in developing of small molecule therapies for treatment in oncology in Poland, European Union, and internationally.
RVU
zł14.90
7D
-2.7%
1Y
-52.8%
Molecure
Market Cap: zł119.5m
A biotechnology company, engages in discovering, developing, and commercializing therapeutics for neoplastic and inflammatory diseases in Poland.
MOC
zł5.80
7D
-2.0%
1Y
1.0%
Poltreg
Market Cap: zł116.0m
A biotechnology company, researches and develops therapies for autoimmune diseases.
PTG
zł19.60
7D
2.3%
1Y
-38.4%